SMMT
#825
Summit Therapeutics Inc. - Common Stock
14.8 5 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.62%
Monthly Change
+14.23%
6 month change
-25.13%
Year Change
-25.23%
Previous Close
15.2 5
Open
15.1 1
Low
14.7 9
High
15.1 5
Volume
1 403
Financials
- Market Capitalization 11.53 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.15
Price to sales ratio
-21.44 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 734 |  EXEL Exelixis, Inc. - Common Stock | 55.89 USD | -1.08% | +0.65% | +4.47% | +43.16% | 14.05 B USD | ||
| 805 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 529.67 USD | -1.31% | +0.46% | +11.68% | +25.04% | 12.21 B USD | ||
| 831 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 227.21 USD | -2.82% | -5.49% | -10.21% | +74.51% | 11.69 B USD | ||
| 846 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 58.79 USD | -0.56% | +0.24% | +5.85% | +1.33% | 11.36 B USD |
Frequently asked questions about Summit Therapeutics Inc. - Common Stock
What is the Summit Therapeutics Inc. - Common Stock stock price today?
The current price of Summit Therapeutics Inc. - Common Stock (SMMT) is 14.85. Over the past 24 hours, the stock has changed by -2.62%. Follow the SMMT chart for real-time price dynamics.
What is the stock ticker of Summit Therapeutics Inc. - Common Stock?
Summit Therapeutics Inc. - Common Stock trades under the ticker SMMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Summit Therapeutics Inc. - Common Stock stock going up?
SMMT has changed by -4.69% over the last week, +14.23% over the last month, and -25.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Summit Therapeutics Inc. - Common Stock net income for the last quarter?
Summit Therapeutics Inc. - Common Stock reported net income of -189.42 M for the last quarter. The previous quarter showed -219.17 M, which means net income changed by +13.57%.
How many employees does Summit Therapeutics Inc. - Common Stock have?
As of the latest available data, Summit Therapeutics Inc. - Common Stock has 265 employees. Workforce size can provide additional context about the company's scale and operations.
What is Summit Therapeutics Inc. - Common Stock EBITDA?
Summit Therapeutics Inc. - Common Stock EBITDA is -199.45 M, and its EBITDA margin is 321.69 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Summit Therapeutics Inc. - Common Stock stock?
You can buy Summit Therapeutics Inc. - Common Stock (SMMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Summit Therapeutics Inc. - Common Stock stock?
Investing in Summit Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SMMT chart and related analysis on metatrader.com as part of your research.